Skip to main navigation Skip to search Skip to main content

A 36-Week Randomized Trial of Bevacizumab and Ranibizumab for Diabetic Macular Edema

  • Richard Lee

Research output: Contribution to journal › Article (Academic Journal) › peer-review

19 Citations (Scopus)
Original languageEnglish
Pages (from-to)841-849
JournalOphthalmology
Volume123
Issue number4
Publication statusPublished - 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Handle.net

Cite this